Another possibility is that, while PRDX2 may act as a procarcinogenic factor early in carcinogenesis, its expression in later stages of HCC may be decreased by intensive and persistent oxidative stress in aggressive tumors. This evidence concerns the gene PRDX2 and hepatocellular carcinoma.